AbCellera Biologics Inc. ABCL Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s software and technology licenses, net?
- AbCellera Biologics Inc. (ABCL) reported software and technology licenses, net of $69.14M in Q1 2026.
- How has AbCellera Biologics Inc.'s software and technology licenses, net changed year-over-year?
- AbCellera Biologics Inc.'s software and technology licenses, net increased by 12.3% year-over-year, from $61.56M to $69.14M.
- What is the long-term trend for AbCellera Biologics Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s software and technology licenses, net has grown at a 44.0% compound annual growth rate (CAGR), from $8.39M to $51.95M.